{"id":"f6faa94b-ac7b-488d-9432-df41acc518b5","kind":"news","code":"f6faa94b-ac7b-488d-9432-df41acc518b5","name":"Aureka Biotechnologies raises USD 35 million in Series A+ financing","nameBasis":"translated-title","summary":"On 2026-04-28, according to Xiniu Data, Aureka Biotechnologies completed Series A+ financing, raising USD 35 million. Investors were lead investor Hongshan China, Jingwei Venture Capital, Boyuan Capital, Wuyuan Capital and others. The company is a developer of antibody drugs using generative AI.","description":"","country":null,"category":null,"originalName":"Aureka Biotechnologies完成A+轮融资，金额3500万美元","eventDate":"2026-04-28T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-19T06:08:30.047Z","englishUpdatedAt":"2026-10-20T18:23:00.946Z","reviewedAt":"2026-10-20T18:23:00.946Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"b37c987502d3629b428e3864f097d2be526d46e092b53faa85b5821f625d3bf1","companyId":"45d3d734-4612-4acd-93a4-8687ab7e94ca","foundedYear":null,"logoUrl":null,"originalText":"2026年4月28日，据烯牛数据报道，Aureka Biotechnologies完成A+轮融资，金额3500万美元。投资方为红杉中国领投、经纬创投、博远资本、五源资本等。该公司为人工智能生成式抗体药物开发商。","sources":[],"related":[{"id":"45d3d734-4612-4acd-93a4-8687ab7e94ca","kind":"companies","code":"UB-C5576","name":"Aureka Biotechnologies","nameBasis":"source-english","summary":"Antibody drug discovery driven by generative AI and digital biology","description":"","country":null,"category":null,"originalName":"Aureka Biotechnologies","eventDate":null,"website":"https://www.aurekabio.com/","sourceUpdatedAt":"2026-10-08T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:23:30.014Z","reviewedAt":"2026-10-20T18:23:30.014Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"3bd42e5b778768ce4e8c1f0761b984ee7ceb9b5700c511566f259d9de0713575","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/aureka-biotechnologies"},{"id":"d201fb3f-4316-4750-8c23-69214a9dec41","kind":"institutions","code":"UB-I2854","name":"Boyuan Capital","nameBasis":"transliterated","summary":"A healthcare venture capital firm.","description":"A healthcare venture capital firm.","country":null,"category":null,"originalName":"博远资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:12:23.417Z","englishUpdatedAt":"2026-10-15T18:21:17.307Z","reviewedAt":"2026-10-15T18:21:17.307Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"079faf2646fb4cbaf7e703d4399ce7e80df58e151b4ce446979177f825b34c9c","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/UB-I2854"},{"id":"9c76fb30-02ff-4e90-8a49-7affc195e15f","kind":"institutions","code":"UB-I022","name":"Hongshan China","nameBasis":"transliterated","summary":"The China branch of leading global venture capital firm Sequoia Capital, covering TMT, consumer businesses, healthcare, and AI, with notable investments including ByteDance, Meituan, Pinduoduo, and JD.com.","description":"The China branch of leading global venture capital firm Sequoia Capital, covering TMT, consumer businesses, healthcare, and AI, with notable investments including ByteDance, Meituan, Pinduoduo, and JD.com.","country":null,"category":null,"originalName":"红杉中国","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:24.320Z","englishUpdatedAt":"2026-10-15T21:44:38.216Z","reviewedAt":"2026-10-15T21:44:38.216Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"a2c7ecf34846fd8e589f711ac888475c5c3cea4f3df39b6b1905d9cbaadeb827","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/hongshan-china"},{"id":"9479d7c1-e67a-44d8-8e1e-7c02c9d1af7d","kind":"institutions","code":"UB-I209","name":"Jingwei Venture Capital","nameBasis":"transliterated","summary":"A prominent Chinese early-stage venture capital firm, formerly Matrix Partners China, focused on early-stage technology, consumer, healthcare, and other investments.","description":"A prominent Chinese early-stage venture capital firm, formerly Matrix Partners China, focused on early-stage technology, consumer, healthcare, and other investments.","country":null,"category":null,"originalName":"经纬创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:19.457Z","englishUpdatedAt":"2026-10-15T21:39:21.207Z","reviewedAt":"2026-10-15T21:39:21.207Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"fc153d78fb297c01b8830bd5dec0843514a8205f64f028c590a92825203f7cc4","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/jingwei-venture-capital"},{"id":"c7b087a5-ed8c-4bc9-92dc-edade94beb0b","kind":"institutions","code":"UB-I570","name":"Niuerli Capital","nameBasis":"transliterated","summary":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","description":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","country":null,"category":null,"originalName":"纽尔利资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:34:26.013Z","englishUpdatedAt":"2026-10-15T18:43:03.796Z","reviewedAt":"2026-10-15T18:43:03.796Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"20eec776f98123320e240f6d1c63ee5204b7eb8d87f0bb01357cfcd4cd70bae5","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/niuerli-capital"},{"id":"53b8bbea-57c1-4fc4-aa07-170e7dc156e4","kind":"institutions","code":"UB-I235","name":"Qiming Venture Capital","nameBasis":"transliterated","summary":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","description":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","country":null,"category":null,"originalName":"启明创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:21.507Z","englishUpdatedAt":"2026-10-15T21:37:02.669Z","reviewedAt":"2026-10-15T21:37:02.669Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"91416aa941c85812e1db97ffa3575271ef78edc44c579f705171db1c1638f73d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/qiming-venture-capital"},{"id":"ff7d41a5-b7cd-44a1-a23b-bc9e082639a4","kind":"institutions","code":"UB-I016","name":"Wuyuan Capital","nameBasis":"transliterated","summary":"A prominent venture capital firm, formerly Morningside Capital, covering technology, consumer businesses, and healthcare, with notable investments including XPeng, Kuaishou, and SenseTime.","description":"A prominent venture capital firm, formerly Morningside Capital, covering technology, consumer businesses, and healthcare, with notable investments including XPeng, Kuaishou, and SenseTime.","country":null,"category":null,"originalName":"五源资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:24.242Z","englishUpdatedAt":"2026-10-15T21:43:23.741Z","reviewedAt":"2026-10-15T21:43:23.741Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"7368ba44c3815996c52f9d8d28ae59336c59aa7539208a5ef5949f6cc0f793e0","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/wuyuan-capital"}],"path":"/news/f6faa94b-ac7b-488d-9432-df41acc518b5","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Aureka Biotechnologies","path":"/companies/aureka-biotechnologies"}},"canonical":"https://uniquebase.ai/news/f6faa94b-ac7b-488d-9432-df41acc518b5"}